Stimac Vlado, Alihodzic Sulejman, Lazarevski Gorjana, Mutak Stjepan, Istuk Zorica Marusic, Fajdetic Andrea, Palej Ivana, Paljetak Hana Cipcic, Marsic Natasa, Padovan Jasna, Tavcar Branka, Erakovic Haber Vesna
GSK Research Centre Zagreb Ltd, Zagreb, Croatia.
J Antibiot (Tokyo). 2009 Mar;62(3):133-44. doi: 10.1038/ja.2009.1. Epub 2009 Feb 13.
A series of 4''-O-acyl derivatives of 8a-aza-8a-homoerythromycins A were synthesized and tested against Gram-positive and Gram-negative bacteria. Derivatives of 8a-aza-8a-homoerythromycin A have potent anti-bacterial activity against not only azithromycin-susceptible strains, but also efflux (M) and inducible macrolide-lincosamide-streptogramin-resistant Gram-positive pathogens. These compounds show moderate to high clearance and low oral bioavailability in preliminary in vivo pharmacokinetic studies in rat.
合成了一系列8a-氮杂-8a-高红霉素A的4''-O-酰基衍生物,并对革兰氏阳性菌和革兰氏阴性菌进行了测试。8a-氮杂-8a-高红霉素A的衍生物不仅对阿奇霉素敏感菌株具有强大的抗菌活性,而且对流出(M)型和诱导型大环内酯-林可酰胺-链阳菌素耐药革兰氏阳性病原体也有抗菌活性。在大鼠的初步体内药代动力学研究中,这些化合物显示出中度至高清除率和低口服生物利用度。